Julien Seneschal

Professor in Dermatology

University of Bordeaux

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Julien Seneschal is a Professor in Dermatology at the University of Bordeaux, France. His research focuses on dermatological conditions, particularly autoimmune diseases such as alopecia areata and vitiligo. Recent publications include studies on the effectiveness of various treatments and the underlying immune mechanisms associated with these skin disorders.

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (6)

Nick J. Reynolds

UNITED KINGDOM

View details

Amit G. Pandya

UNITED STATES

View details

Katia Boniface

Professor in Thérapeutic Innovtion

University of Bordeaux

FRANCE

View details

C. Vestergaard

DENMARK

View details

Meri K. Tulic

Université Côte d'Azur

FRANCE

View details

T. Passeron

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Julien Seneschal

Research Interests

Explore related searches

Contact this professor

About

Articles (23)

Real‐life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre study

Refractory anogenital Hailey‐Hailey disease successfully treated with topical ruxolitinib

Regulatory T Cell Dysregulation in Vitiligo: A Meta‐Analysis and Systematic Review of Immune Mechanisms and Therapeutic Perspectives

Unveiling the Unseen: Exploring Cellular Dynamics in Nonlesional Vitiligo Skin

Evaluation of the repigmentation of facial vitiligo using an AI algorithm in a phase 2 study

Clinical heterogeneity in vitiligo: Identification of clinical markers based patient clusters

Alopecia areata and ritlecitinib: Unravelling response trajectories

Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 Studies

The atopic dermatitis patient journey: insights from a qualitative study

Repigmentation by body region in patients with vitiligo treated with ruxolitinib cream over 52 weeks

Impact of xerosis cutis, with or without skin disease, on health‐related quality of life: A prospective study

Alopecia areata: Time for position statement to include new systemic therapeutic advances

Demographic and clinical characteristics of patients with coexistence of systemic sclerosis and atopy: A cross‐sectional study

Efficacy and safety of the combination of steroid pulse therapy with methotrexate for vitiligo: A pilot retrospective case series

Impact of house dust mite in vitiligo skin: environmental contribution to increased cutaneous immunity and melanocyte detachment

Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force—Part 2: Specific treatment recommendations

Clinician‐reported outcome measures for the assessment of vitiligo: A scoping review

Vitiligo patient population and disease burden in France: VIOLIN study results from the CONSTANCES cohort

Evaluation of facial vitiligo severity with a mixed clinical and artificial intelligence approach

Health literacy and topical corticosteroid adherence in parents of children with atopic dermatitis in France

Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce

Alopecia areata: Recent advances and emerging therapies.

Longer dupilumab dosing intervals in adult patients with atopic dermatitis: experience from a French multicentre retrospective cohort study

Collaborators (6)

Nick J. Reynolds

Amit G. Pandya

Katia Boniface

C. Vestergaard

Meri K. Tulic

T. Passeron

Make your next move.